Abiopharma

(10% Negative) XILIO THERAPEUTICS, INC. (XLO) Announces Business Combination

(99% Neutral) HALOZYME THERAPEUTICS, INC. (HALO) Announces Business Combination

(30% Negative) THERIVA BIOLOGICS, INC. (TOVX) Reports Q1 2026 Financial Results

(80% Positive) ATARA BIOTHERAPEUTICS, INC. (ATRA) Announces Regulatory Update

(30% Negative) CANDEL THERAPEUTICS, INC. (CADL) Reports Q1 2026 Financial Results

(30% Negative) CENTURY THERAPEUTICS, INC. (IPSC) Reports Q1 2026 Financial Results

(19% Negative) CADRENAL THERAPEUTICS, INC. (CVKD) Announces Delay in diabetes Trials for non-obese diabetic mice Due to Patient Enrollment Issues, Regulatory Process

(99% Neutral) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on study for gross proceeds

(97% Positive) INTEGER HOLDINGS CORPORATION (ITGR) Announces Business Combination

(10% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in opportunity Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment